Publicacións en colaboración con investigadores/as de Universidade da Coruña (17)

2024

  1. Injectable Carrageenan/Green Graphene Oxide Hydrogel: A Comprehensive Analysis of Mechanical, Rheological, and Biocompatibility Properties

    Polymers, Vol. 16, Núm. 16

2023

  1. Injectable hybrid hydrogels physically crosslinked based on carrageenan and green graphene for tissue repair

    International Journal of Biological Macromolecules, Vol. 235

2022

  1. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. Relaxin has beneficial effects on liver lipidome and metabolic enzymes

    FASEB Journal, Vol. 35, Núm. 7

2020

  1. Carrageenan-based physically crosslinked injectable hydrogel for wound healing and tissue repairing applications

    International Journal of Pharmaceutics, Vol. 589

  2. Poly(hydroxybutyrate-co-hydroxyvalerate) microparticles embedded in κ-carrageenan/locust bean gum hydrogel as a dual drug delivery carrier

    International Journal of Biological Macromolecules, Vol. 146, pp. 110-118

2019

  1. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  2. Entrapment of chitosan, pectin or κ-carrageenan within methacrylate based hydrogels: Effect on swelling and mechanical properties

    Materials Science and Engineering C, Vol. 96, pp. 583-590

  3. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity

    International Journal of Pharmaceutics, Vol. 568

  4. Poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/cellulose nanocrystal films: artificial weathering, humidity absorption, water vapor transmission rate, antimicrobial activity and biocompatibility

    Cellulose, Vol. 26, Núm. 4, pp. 2333-2348

2016

  1. Pollutants make rheumatic diseases worse: Facts on polychlorinated biphenyls (PCBs) exposure and rheumatic diseases

    Life Sciences, Vol. 157, pp. 140-144

  2. The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1

    Scientific Reports, Vol. 6

2015

  1. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

  2. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: A brief history

    Drug Discovery Today

  3. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

    Biomarkers, Vol. 20, Núm. 8, pp. 565-571

2014

  1. Bone metabolism and adipokines: Are there perspectives for bone diseases drug discovery?

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 8, pp. 945-957

  2. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals

    Annals of the Rheumatic Diseases